SingletO2 Therapeutics-preview

Singleto2

SingletO2 Therapeutics

Private

New Providence, New JerseyHealthcare & Life Scienceshttps://www.singleto2.com/

Last Round

Grant

Apr 12, 2024

Total Funding Raised

$2.22M

Company Overview

SingletO2 Therapeutics is a drug discovery company that develops treatments using singlet oxygen to treat periodontal disease without surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Water Treatment

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

photodynamic therapyperiodontal disease treatmentsinglet oxygenmedical devicegum disease treatmentnon-surgical treatmentantibiotic-free treatmentperiodonticsMedTechsuperhydrophobic photodynamic therapySH-PDTantimicrobial therapywound carewater purification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SingletO2 Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SingletO2 Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 12, 2024
Grant	Aug 1, 2021
Grant	Sep 1, 2017
Grant	Sep 1, 2016

View all Funding Rounds

SingletO2 Therapeutics Investors

Notable investors and investment history

Investor	Rounds
National Institute of Allergy and Infectious Diseases	Grant
NIH RADx	Grant
National Institute of Dental and Craniofacial Research	Grant
America's Seed Fund	Grant
National Science Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 12, 2024
$300K grant from National Institute of Allergy and Infectious Diseases.
Aug 1, 2021
$256K received from National Science Foundation and America's Seed Fund.

View all signals

SingletO2 Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SingletO2 Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SingletO2 Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Providence, New Jersey

Year Founded2015

Last FundingApr 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.